focus -WSS

focus

author：hotspot 2025-09-28 02:27:09 - browse：97737

Blood corpuscles in clot — Inari will pay $250 million upfront and $165 more depending on LimFlow’s commercial success. David Gregory & Debbie Marshall/Wellcome Images

Vascular device maker Inari Medical announced plans to buy LimFlow, a company selling a last-line therapy to save legs with blocked blood flow, on Wednesday. Inari will pay $250 million upfront and $165 more depending on LimFlow’s commercial success.

LimFlow recently snagged Food and Drug Administration approval for its surgical system that uses a stent to connect a blocked artery to an open vein, thus allowing blood to flow through and heal injuries. The tool is meant only for patients with a severe form of peripheral artery disease, and who have already tried more conservative options.

Dan Rose, CEO of LimFlow, previously told STAT that his mission is to fight the amputation epidemic in the United States, which disproportionately impacts Black patients. Experts cautioned to STAT that expanding screenings to catch the disease early is still the most important measure.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： EPA limits use of carcinogenic gas for sterilizing medical devices

entertainment

WSS

Boston's new lab space is opening empty

President Biden's budget: Here's what you might have missed

STAT Madness 2024: Meet the contenders

How many hemophilia patients actually want gene therapy?

President Biden's budget: Here's what you might have missed

CDC panel: People 65 and older should get a Covid spring booster shot

leisure time

focus

explore

DIEP, the 'gold standard' of breast reconstruction, is under threat

President Biden's budget: Here's what you might have missed

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

How one medical school became remarkably diverse

CDC panel: People 65 and older should get a Covid spring booster shot

In Memoriam: Notable people who died in 2023

As AI in medicine takes off, can 'human in the loop' prevent harm?

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

STAT Madness 2024: Meet the contenders

leisure time

John Green on his newest strategy for fighting tuberculosis

5 ways to address the shortage of health care workers

Readout Newsletter: CAR

Virtual repurposing can help discover new uses for existing drugs

Virtual repurposing can help discover new uses for existing drugs

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

Wikipedia

Wikipedia

entertainment

knowledge